Skip to main content
SpringerLink
Log in
Book cover

Principles of Molecular Cardiology pp 185–201Cite as

Atherosclerosis

  • Chapter

  • 912 Accesses

Part of the book series: Contemporary Cardiology ((CONCARD))

Abstract

Cardiovascular disease, the most common cause of death in the developed world (1), causes more deaths in the United States than the next six leading causes combined. More than 2600 Americans die of cardiovascular disease each day. Furthermore, more than 12 million Americans have coronary artery disease, and more than 4.5 million have suffered a stroke. The American Heart Association (AHA) estimates that 20% of the population has some form of cardiovascular disease (2). These startling statistics are accurate despite a 22% decrease from 1988 to 1998 in death rates from cardiovascular disease.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Yusuf S, Reddy S, Ounpuu S, Anand S. Global Burden of Cardiovascular Diseases: Part I: General Considerations, the Epidemiologic Transition, Risk Factors, and Impact of Urbanization. Circulation 2001;104:2746–2753.

    Article  PubMed  CAS  Google Scholar 

  2. American Heart Association. 2002 Heart and Stroke Statistical Update. 2001. Dallas, TX.

    Google Scholar 

  3. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001;344:1608–1621.

    Article  PubMed  CAS  Google Scholar 

  4. Breslow JL. Mouse models of atherosclerosis. Science 1996;272:685–688.

    Article  PubMed  CAS  Google Scholar 

  5. Gimbrone MA Jr. Vascular endothelium, hemodynamic forces, and atherogenesis. Am J Pathol 1999;155:1–5.

    PubMed  Google Scholar 

  6. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:1355–1374.

    PubMed  CAS  Google Scholar 

  7. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994;89:2462–2478.

    PubMed  CAS  Google Scholar 

  8. Stary HC, Blankenhorn DH, Chandler AB, et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1992;85:391–405.

    PubMed  CAS  Google Scholar 

  9. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vase Biol 2000;20:1262–1275.

    CAS  Google Scholar 

  10. Stary HC. Composition and classification of human atherosclerotic lesions. Virchows Arch A Pathol Anat Histopathol 1992;421:277–290.

    Article  PubMed  CAS  Google Scholar 

  11. Stary HC. Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vase Biol 2000;20:1177–1178.

    CAS  Google Scholar 

  12. Pasquinelli G, Preda P, Gargiulo M, et al. An immunohisto-chemical study of inflammatory abdominal aortic aneurysms. J Submicrosc Cytol Pathol 1993;25:103–112.

    PubMed  CAS  Google Scholar 

  13. Newman KM, Malon AM, Shin RD, Scholes JV, Ramey WG, Tilson MD. Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources. Connect Tissue Res 1994;30:265–276.

    PubMed  CAS  Google Scholar 

  14. Newman KM, Ogata Y, Malon AM, et al. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb 1994;14:1315–1320.

    PubMed  CAS  Google Scholar 

  15. Carrell TW, Burnand KG, Wells GM, Clements JM, Smith A. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 2002;105:477–482.

    Article  PubMed  CAS  Google Scholar 

  16. Von Rokitansky C. A manual of pathological anatomy. Berlin: Sydenham Society; 1852.

    Google Scholar 

  17. Li H, Cybulsky MI, Gimbrone MA Jr., Libby P. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am J Pathol 1993;143:1551–1559.

    PubMed  CAS  Google Scholar 

  18. Lusis AJ. Atherosclerosis. Nature 2000;407:233–241.

    Article  PubMed  CAS  Google Scholar 

  19. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115–126.

    Article  PubMed  CAS  Google Scholar 

  20. De Caterina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995;96:60–68.

    PubMed  Google Scholar 

  21. Verma S, Anderson T. Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002;105:546–549.

    Article  PubMed  CAS  Google Scholar 

  22. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:154–160.

    Article  PubMed  CAS  Google Scholar 

  23. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383–1389.

    Google Scholar 

  24. Witztum JL, Steinberg D. The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc Med 2001;11:93–102.

    Article  PubMed  CAS  Google Scholar 

  25. Parthasarathy S, Santanam N, Ramachandran S, Meilhac O. Oxidants and antioxidants in atherogenesis. An appraisal. J Lipid Res 1999;40:2143–2157.

    PubMed  CAS  Google Scholar 

  26. Yla-Herttuala S, Palinski W, Rosenfeld ME, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086–1095.

    PubMed  CAS  Google Scholar 

  27. Riley SJ, Stouffer GA. Cardiology Grand Rounds from the University of North Carolina at Chapel Hill. The antioxidant vitamins and coronary heart disease: Part 1. Basic science background and clinical observational studies. Am J Med Sci 2002; 324:314–320.

    Article  PubMed  Google Scholar 

  28. Riley SJ, Stouffer GA. Cardiology Grand Rounds from the University of North Carolina at Chapel Hill. The antioxidant vitamins and coronary heart disease: Part II. Randomized clinical trials. Am J Med Sci 2003;325:15–19.

    Article  PubMed  Google Scholar 

  29. Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997;349:1715–1720.

    Article  PubMed  CAS  Google Scholar 

  30. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781–786.

    Article  PubMed  CAS  Google Scholar 

  31. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447–455.

    Article  Google Scholar 

  32. Omenn GS, Goodman GE, Thomquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150–1155.

    Article  PubMed  CAS  Google Scholar 

  33. Patterson C, Ballinger S, Stouffer GA, Runge MS. Antioxidant vitamins: Sorting out the good and the not so good. J Am Coll Cardiol 1999;34:1216–1218.

    Article  PubMed  CAS  Google Scholar 

  34. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135–1143.

    Article  PubMed  CAS  Google Scholar 

  35. Kruth HS. Macrophage foam cells and atherosclerosis. Front Biosci 2001;6:D429–D455.

    Article  PubMed  CAS  Google Scholar 

  36. Hansson GK, Jonasson L, Seifert PS, Stemme S. Immune mechanisms in atherosclerosis. Arteriosclerosis 1989;9:567–578.

    PubMed  CAS  Google Scholar 

  37. Hansson GK, Holm J. Interferon-γ inhibits arterial stenosis after injury. Circulation 1991;84:1266–1272.

    PubMed  CAS  Google Scholar 

  38. van der Wai AC, Piek JJ, de Boer OJ, et al. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart 1998;80:14–18.

    Google Scholar 

  39. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404–407.

    PubMed  CAS  Google Scholar 

  40. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet 1997;350:404–407.

    Article  PubMed  CAS  Google Scholar 

  41. Neumann F, Kastrati A, Miethke T, et al. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial. Lancet 2001;357:2085–2089.

    Article  PubMed  CAS  Google Scholar 

  42. Muhlestein JB, Anderson JL, Carlquist JF, et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation 2000;102:1755–1760.

    PubMed  CAS  Google Scholar 

  43. Gieffers J, Fullgraf H, Jahn J, et al. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 2001;103:351–356.

    PubMed  CAS  Google Scholar 

  44. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999;100:e20–e28.

    PubMed  CAS  Google Scholar 

  45. de Boer OJ, van der Wai AC, Becker AE. Atherosclerosis, inflammation, and infection. J Pathol 2000;190:237–243.

    Article  PubMed  Google Scholar 

  46. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vase Biol 2001;21:1876–1890.

    Article  CAS  Google Scholar 

  47. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1973;70:1753–1756.

    Article  PubMed  CAS  Google Scholar 

  48. Murry CE, Gipaya CT, Bartosek T, Benditt EP, Schwartz SM. Monoclonality of smooth muscle cells in human atherosclerosis. Am J Pathol 1997;151:697–705.

    PubMed  CAS  Google Scholar 

  49. Pearson TA, Wang BA, Solez K, Heptinstall RH. Clonal characteristics of fibrous plaques and fatty streaks from human aortas. Am J Pathol 1975;81:379–387.

    PubMed  CAS  Google Scholar 

  50. Schwartz SM, Murry CE. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu Rev Med 1998;49:437–460.

    Article  PubMed  CAS  Google Scholar 

  51. Proudfoot D, Shanahan CM. Biology of calcification in vascular cells: intima versus media. Herz 2001;26:245–251.

    Article  PubMed  CAS  Google Scholar 

  52. Bostrom K, Demer LL. Regulatory mechanisms in vascular calcification. Crit Rev Eukaryot Gene Expr 2000;10:151–158.

    PubMed  CAS  Google Scholar 

  53. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371–1375.

    Article  PubMed  CAS  Google Scholar 

  54. Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation 2001;103:604–616.

    PubMed  CAS  Google Scholar 

  55. Pasterkamp G, Schoneveld AH, van Wolferen W, et al. The impact of atherosclerotic arterial remodeling on percentage of luminal stenosis varies widely within the arterial system. A postmortem study. Arterioscler Thromb Vase Biol 1997;7:3057–3063.

    Google Scholar 

  56. Ward MR, Pasterkamp G, Yeung AC, Borst C. Arterial remodeling. Mechanisms and clinical implications. Circulation 2000;102:1186–1191.

    PubMed  CAS  Google Scholar 

  57. Mintz GS, Kent KM, Pichard AD, Satler LF, Popma JJ, Leon MB. Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. Circulation 1997;95:1791–1798.

    PubMed  CAS  Google Scholar 

  58. Smits PC, Pasterkamp G, de Jaegere PP, de Feyter PJ, Borst C. Angioscopic complex lesions are predominantly compensatory enlarged: an angioscopy and intracoronary ultrasound study. Cardiovasc Res 1999;41:458–464.

    Article  PubMed  CAS  Google Scholar 

  59. Kimura T, Kaburagi S, Tamura T, et al. Remodeling of human coronary arteries undergoing coronary angioplasty or atherec-tomy. Circulation 1997;96:475–4183.

    PubMed  CAS  Google Scholar 

  60. Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996;94:35–43.

    PubMed  CAS  Google Scholar 

  61. Dangas G, Mintz GS, Mehran R, et al. Preintervention arterial remodeling as an independent predictor of target-lesion revascularization after nonstent coronary intervention: an analysis of 777 lesions with intravascular ultrasound imaging. Circulation 1999;99:3149–3154.

    PubMed  CAS  Google Scholar 

  62. Murabito JM, Evans JC, Larson MG, Levy D. Prognosis after the onset of coronary heart disease. An investigation of differences in outcome between the sexes according to initial coronary disease presentation. Circulation 1993;88:2548–2555.

    PubMed  CAS  Google Scholar 

  63. Mizuno K, Satomura K, Miyamoto A, et al. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med 1992;326:287–291.

    Article  PubMed  CAS  Google Scholar 

  64. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985 71:699–708.

    PubMed  CAS  Google Scholar 

  65. Rauch U, Osende JI, Fuster V, Badimon JJ, Fayad Z, Chesebro JH. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med 2001;134:224–238.

    PubMed  CAS  Google Scholar 

  66. Gersh BJ, Braunwald E, Rutherford JD. Chronic coronary artery disease. In: Braunwald E, ed. Heart Disease. 5th ed. Philadelphia: W.B. Saunders; 1997:1289–1365.

    Google Scholar 

  67. Ambrose JA, Weinrauch M. Thrombosis in ischemic heart disease. Arch Intern Med 1996;156:1382–1394.

    Article  PubMed  CAS  Google Scholar 

  68. Silva JA, Escobar A, Collins TJ, Ramee SR, White CJ. Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients. Circulation 1995;92:1731–1736.

    PubMed  CAS  Google Scholar 

  69. de Feyter PJ, Ozaki Y, Baptista J, et al. Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation 1995;92:1408–1413.

    PubMed  Google Scholar 

  70. Tabata H, Mizuno K, Arakawa K, et al. Angioscopic identification of coronary thrombus in patients with postinfarction angina. J Am Coll Cardiol 1995;25:1282–1285.

    Article  PubMed  CAS  Google Scholar 

  71. Lewis HD, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 1983;309:396–403.

    Article  PubMed  Google Scholar 

  72. Cairns JA, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or both in unstable angina. N Engl J Med 1985;313:1369–1375.

    Article  PubMed  CAS  Google Scholar 

  73. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin or both to treat unstable angina. N Engl J Med 1988;319:1105–1111.

    Article  PubMed  CAS  Google Scholar 

  74. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary disease. Lancet 1990;336:827–830.

    Article  Google Scholar 

  75. ISIS Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349–360.

    Google Scholar 

  76. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 1994;308:159–168.

    Google Scholar 

  77. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81–106.

    Google Scholar 

  78. Llevadot J, Giugliano RP, Antman EM. Bolus fibrinolytic therapy in acute myocardial infarction. JAMA 2001;286:442–449.

    Article  PubMed  CAS  Google Scholar 

  79. Fibrinolytic Therapy Trialists’(FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311–322.

    Google Scholar 

  80. The PRISM Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 1998;338:1498–1505.

    Article  Google Scholar 

  81. The PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein Ilb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338:1488–1497.

    Article  Google Scholar 

  82. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein Ilb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein Ilb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med 1998;339:436–443.

    Article  Google Scholar 

  83. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984;310:1137–1140.

    Article  PubMed  CAS  Google Scholar 

  84. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988;12:56–62.

    Article  PubMed  CAS  Google Scholar 

  85. Smith SC Jr. Risk-reduction therapy: the challenge to change. Circulation 1996;93:2205–2211.

    PubMed  Google Scholar 

  86. Davies MJ, Bland JM, Hangartner JR, Angelini A, Thomas AC. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. Eur Heart J 1989; 10:203–208.

    PubMed  CAS  Google Scholar 

  87. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657–671.

    PubMed  CAS  Google Scholar 

  88. Ojio S, Takatsu H, Tanaka T, et al. Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: coronary angiographic findings within 1 week before the onset of infarction. Circulation 2000;102:2063–2069.

    PubMed  CAS  Google Scholar 

  89. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93:1354–1363.

    PubMed  CAS  Google Scholar 

  90. Ardissino D, Merlini PA, Bauer KA, et al. Thrombogenic potential of human coronary atherosclerotic plaques. Blood 2001;98:2726–2729.

    Article  PubMed  CAS  Google Scholar 

  91. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336:1276–1282.

    Article  PubMed  CAS  Google Scholar 

  92. Varnava AM, Mills PG, Davies MJ. Relationship between coronary artery remodeling and plaque vulnerability. Circulation 2002;105:939–943.

    Article  PubMed  Google Scholar 

  93. Murphy G, Stanton H, Cowell S, et al. Mechanisms for pro matrix metalloproteinase activation. APMIS 1999;107:38–44.

    Article  PubMed  CAS  Google Scholar 

  94. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493–2503.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC

    George A. Stouffer MD

Authors
  1. George A. Stouffer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, UNC School of Medicine, Chapell Hill, NC

    Marschall S. Runge MD, PhD

  2. Carolina Cardiovascular Biology Center, Chapel Hill, NC

    Cam Patterson MD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Stouffer, G.A. (2005). Atherosclerosis. In: Runge, M.S., Patterson, C. (eds) Principles of Molecular Cardiology. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59259-878-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-878-6_12

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-201-8

  • Online ISBN: 978-1-59259-878-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation